“Delaying the Onset of Type 1 Diabetes With Teplizumab: A Narrative Review of Autoantibody Screening and Who Would Actually Be Treated”. Journal of Clinical Diabetes and Obesity 2, no. 1 (October 10, 2022): 7–12. Accessed October 30, 2026. https://pragmajournals.org/index.php/JCDO/article/view/316.